In patients with COPD and atrial fibrillation or flutter, vitamin K antagonists carry a lower 1‑year risk for hospitalization ...

Managing mucus from COPD involves strategies that can help loosen mucus and clear it from your airway, such as staying ...

Stopping long-acting inhalers for chronic obstructive pulmonary disease (COPD) can lead to a sharp rise in flare-ups for ...

Indoor and outdoor pollutants and climate extremes have shown association with COPD exacerbations separately, but these factors also can act synergistically to increase morbidity in patients with high ...

Study finds adults consuming more sugary drinks have higher odds of COPD, highlighting links between diet and lung health.

COPD affects at least 4.5% of those 18-49 years old, according to an analysis of U.S. cohorts. The early COPD group was more likely to be hospitalized or die from chronic respiratory disease, to ...

Short- and long-acting bronchodilators are inhaled medications that can be used separately or in combination to manage COPD.

FLAME analysis suggests COPD exacerbation risk spikes for 3 months after stopping LAMA or ICS, underscoring adherence and careful step-down.

The FDA approved dupilumab (Dupixent) as the first biologic treatment for adults with chronic obstructive pulmonary disease (COPD), Sanofi and Regeneron announced on Friday. An injectable interleukin ...

GSK plc GSK announced that the European Commission has approved its blockbuster respiratory drug, Nucala (mepolizumab), for ...

U.S. adults faced a greater likelihood for COPD if their daily sugar caloric intake from sugar-sweetened beverages was 10% or ...